Cargando…

Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?

BACKGROUND: The pathogenesis of pulmonary hypertension (PH) in hemodialysis is still unclear. The aim of this study was to identify the risk factors associated with the presence of PH in chronic hemodialysis patients and to verify whether these factors might explain the highest mortality among them....

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Hugo Hyung Bok, Martin, Luis Cuadrado, Kochi, Ana Claudia, Rodrigues-Telini, Lidiane Silva, Barretti, Pasqual, Caramori, Jacqueline Teixeira, Matsubara, Beatriz Bojikian, Zannati-Bazan, Silméia Garcia, Franco, Roberto Jorge da Silva, Queluz, Thais Thomaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489568/
https://www.ncbi.nlm.nih.gov/pubmed/22867112
http://dx.doi.org/10.1186/1471-2369-13-80
_version_ 1782248742996410368
author Yoo, Hugo Hyung Bok
Martin, Luis Cuadrado
Kochi, Ana Claudia
Rodrigues-Telini, Lidiane Silva
Barretti, Pasqual
Caramori, Jacqueline Teixeira
Matsubara, Beatriz Bojikian
Zannati-Bazan, Silméia Garcia
Franco, Roberto Jorge da Silva
Queluz, Thais Thomaz
author_facet Yoo, Hugo Hyung Bok
Martin, Luis Cuadrado
Kochi, Ana Claudia
Rodrigues-Telini, Lidiane Silva
Barretti, Pasqual
Caramori, Jacqueline Teixeira
Matsubara, Beatriz Bojikian
Zannati-Bazan, Silméia Garcia
Franco, Roberto Jorge da Silva
Queluz, Thais Thomaz
author_sort Yoo, Hugo Hyung Bok
collection PubMed
description BACKGROUND: The pathogenesis of pulmonary hypertension (PH) in hemodialysis is still unclear. The aim of this study was to identify the risk factors associated with the presence of PH in chronic hemodialysis patients and to verify whether these factors might explain the highest mortality among them. METHODS: We conducted a retrospective study of hemodialysis patients who started treatment from August 2001 to October 2007 and were followed up until April 2011 in a Brazilian referral medical school. According to the results of echocardiography examination, patients were allocated in two groups: those with PH and those without PH. Clinical parameters, site and type of vascular access, bioimpedance, and laboratorial findings were compared between the groups and a logistic regression model was elaborated. Actuarial survival curves were constructed and hazard risk to death was evaluated by Cox regression analysis. RESULTS: PH > 35 mmHg was found in 23 (30.6%) of the 75 patients studied. The groups differed in extracellular water, ventricular thickness, left atrium diameter, and ventricular filling. In a univariate analysis, extracellular water was associated with PH (relative risk = 1.194; 95% CI of 1.006 – 1.416; p = 0.042); nevertheless, in a multiple model, only left atrium enlargement was independently associated with PH (relative risk =1.172; 95% CI of 1.010 – 1.359; p = 0.036). PH (hazard risk = 3.008; 95% CI of 1.285 – 7.043; p = 0.011) and age (hazard risk of 1.034 per year of age; 95% CI of 1.000 – 7.068; p = 0.047) were significantly associated with mortality in a multiple Cox regression analysis. However, when albumin was taken in account the only statistically significant association was between albumin level and mortality (hazard risk = 0.342 per g/dL; 95% CI of 0.119 – 0.984; p = 0.047) while the presence of PH lost its statistical significance (p = 0.184). Mortality was higher in patients with PH (47.8% vs 25%) who also had a statistically worse survival after the sixth year of follow up. CONCLUSIONS: PH in hemodialysis patients is associated with parameters of volume overload that sheds light on its pathophysiology. Mortality is higher in hemodialysis patients with PH and the low albumin level can explain this association.
format Online
Article
Text
id pubmed-3489568
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34895682012-11-08 Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension? Yoo, Hugo Hyung Bok Martin, Luis Cuadrado Kochi, Ana Claudia Rodrigues-Telini, Lidiane Silva Barretti, Pasqual Caramori, Jacqueline Teixeira Matsubara, Beatriz Bojikian Zannati-Bazan, Silméia Garcia Franco, Roberto Jorge da Silva Queluz, Thais Thomaz BMC Nephrol Research Article BACKGROUND: The pathogenesis of pulmonary hypertension (PH) in hemodialysis is still unclear. The aim of this study was to identify the risk factors associated with the presence of PH in chronic hemodialysis patients and to verify whether these factors might explain the highest mortality among them. METHODS: We conducted a retrospective study of hemodialysis patients who started treatment from August 2001 to October 2007 and were followed up until April 2011 in a Brazilian referral medical school. According to the results of echocardiography examination, patients were allocated in two groups: those with PH and those without PH. Clinical parameters, site and type of vascular access, bioimpedance, and laboratorial findings were compared between the groups and a logistic regression model was elaborated. Actuarial survival curves were constructed and hazard risk to death was evaluated by Cox regression analysis. RESULTS: PH > 35 mmHg was found in 23 (30.6%) of the 75 patients studied. The groups differed in extracellular water, ventricular thickness, left atrium diameter, and ventricular filling. In a univariate analysis, extracellular water was associated with PH (relative risk = 1.194; 95% CI of 1.006 – 1.416; p = 0.042); nevertheless, in a multiple model, only left atrium enlargement was independently associated with PH (relative risk =1.172; 95% CI of 1.010 – 1.359; p = 0.036). PH (hazard risk = 3.008; 95% CI of 1.285 – 7.043; p = 0.011) and age (hazard risk of 1.034 per year of age; 95% CI of 1.000 – 7.068; p = 0.047) were significantly associated with mortality in a multiple Cox regression analysis. However, when albumin was taken in account the only statistically significant association was between albumin level and mortality (hazard risk = 0.342 per g/dL; 95% CI of 0.119 – 0.984; p = 0.047) while the presence of PH lost its statistical significance (p = 0.184). Mortality was higher in patients with PH (47.8% vs 25%) who also had a statistically worse survival after the sixth year of follow up. CONCLUSIONS: PH in hemodialysis patients is associated with parameters of volume overload that sheds light on its pathophysiology. Mortality is higher in hemodialysis patients with PH and the low albumin level can explain this association. BioMed Central 2012-08-06 /pmc/articles/PMC3489568/ /pubmed/22867112 http://dx.doi.org/10.1186/1471-2369-13-80 Text en Copyright ©2012 Yoo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yoo, Hugo Hyung Bok
Martin, Luis Cuadrado
Kochi, Ana Claudia
Rodrigues-Telini, Lidiane Silva
Barretti, Pasqual
Caramori, Jacqueline Teixeira
Matsubara, Beatriz Bojikian
Zannati-Bazan, Silméia Garcia
Franco, Roberto Jorge da Silva
Queluz, Thais Thomaz
Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
title Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
title_full Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
title_fullStr Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
title_full_unstemmed Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
title_short Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
title_sort could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489568/
https://www.ncbi.nlm.nih.gov/pubmed/22867112
http://dx.doi.org/10.1186/1471-2369-13-80
work_keys_str_mv AT yoohugohyungbok couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT martinluiscuadrado couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT kochianaclaudia couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT rodriguestelinilidianesilva couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT barrettipasqual couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT caramorijacquelineteixeira couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT matsubarabeatrizbojikian couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT zannatibazansilmeiagarcia couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT francorobertojorgedasilva couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension
AT queluzthaisthomaz couldalbuminlevelexplainthehighermortalityinhemodialysispatientswithpulmonaryhypertension